← Repozitorij


Botta L



Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet-a population-based study. Lancet Oncol. 2017;18(8):1022-39.[Šekerija M]

Autori: Gatta G, Capocaccia R, Botta L, Mallone S, De Angelis R, Ardanaz E, Comber H, Dimitrova N, Leinonen MK, Siesling S, van der Zwan JM, Van Eycken L, Visser O, Žakelj MP, Anderson LA, Bella F, Kaire I, Otter R, Stiller CA, Trama A, RARECAREnet working group
Godina: 2017

Geographical variability in survival of European children with central nervous system tumours. Eur J Cancer. 2017;82:137-48. [Šekerija M]

Autori: Gatta G, Peris-Bonet R, Visser O, Stiller C, Marcos-Gragera R, Sanchez MJ, Lacour B, Kaatsch P, Berrino F, Rutkowski S, Botta L, EUROCARE-5 Working Group
Godina: 2017

Quality analysis of population-based information on cancer stage at diagnosis across Europe, with presentation of stage-specific cancer survival estimates: A EUROCARE-5 study. Eur J Cancer. 2017;84:335-53. [Šekerija M]

Autori: Minicozzi P, Innos K, Sanchez MJ, Trama A, Walsh PM, Marcos-Gragera R, Dimitrova N, Botta L, Visser O, Rossi S, Tavilla A, Sant M, EUROCARE-5 Working Group
Godina: 2017

(Šekerija M) Prognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: The EUROCARE-5 population-based study. European Journal of Cancer. 2015.

Autori: Gatta G, Botta L, Sanchez MJ, Anderson LA, Pierannunzio D, Licitra L
Godina: 2015

(Šekerija M) Survival of adults with primary malignant brain tumours in Europe; Results of the EUROCARE-5 study. European Journal of Cancer. 2015.

Autori: Visser O, Ardanaz E, Botta L, Sant M, Tavilla A, Minicozzi P
Godina: 2015